Form 4: SES AI Officer Sells Shares After Option Exercise

SES AI Corp's Chief Science Officer, Gan Hong, executed a pre-planned sale of 150,000 shares following the exercise of stock options.

Summary

• Gan Hong, Chief Science Officer of SES AI Corp, engaged in a pre-planned transaction on November 17, 2025.
• Exercised options to acquire 150,000 shares of Class A Common Stock at an exercise price of $0.15 per share.
• Immediately sold 150,000 shares of Class A Common Stock at a weighted average price of $1.9015 per share.
• The sale price ranged from $1.85 to $1.99 per share.
• These transactions were conducted under a Rule 10b5-1 plan established on August 14, 2025.
• Following these transactions, Gan Hong beneficially owns 1,253,286 shares of Class A Common Stock, which includes 852,222 shares underlying restricted stock units subject to forfeiture until they vest.
• Gan Hong also holds 93,277 derivative securities in the form of stock options with an exercise price of $0.15, expiring on March 13, 2029.

Sentiment

Score: 6

Explanation: The transaction is neutral to slightly positive. While an insider sale can sometimes be viewed negatively, the execution under a 10b5-1 plan mitigates concerns about opportunistic selling. The officer still retains a significant stake, including RSUs and options, indicating continued alignment with shareholder interests. The profitable exercise and sale also reflect positively on the stock's performance relative to the option strike price.

Positives

• The transactions were executed under a Rule 10b5-1 plan, indicating pre-planned sales and reducing concerns about opportunistic timing.
• The sale price of $1.9015 per share is significantly higher than the exercise price of $0.15, indicating a profitable transaction for the officer.

Negatives

• An officer selling a substantial number of shares could be perceived negatively by some investors, potentially signaling a lack of confidence, although the 10b5-1 plan mitigates this.

Future Outlook

NA

Industry Context

This is an insider transaction filing (Form 4) and does not provide information directly related to broader industry trends or competitive landscape. It reflects an individual officer's personal financial planning.

Stakeholder Impact

• Shareholders: May view the sale with slight caution, but the 10b5-1 plan provides transparency. The officer retains a significant stake, maintaining alignment.
• Employees: No direct impact mentioned.

Key Dates

Recommendation

The Form 4 filing details a pre-planned insider transaction by the Chief Science Officer, involving the exercise of options and subsequent sale of shares under a Rule 10b5-1 plan. This type of transaction is generally considered routine for executive compensation and personal financial planning, rather than a signal of changing company fundamentals or outlook. The officer retains a substantial beneficial ownership, including significant restricted stock units and additional options. While a sale by an insider might prompt some scrutiny, the pre-arranged nature mitigates concerns about opportunistic timing. Therefore, this specific filing does not provide new information that would warrant a change in investment thesis; a 'hold' recommendation is appropriate, pending further fundamental analysis of the company's operations and financial performance.

Keywords

SES AI Corp, SES, Form 4, Insider Trading, Stock Option Exercise, Share Sale, Gan Hong, Chief Science Officer, 10b5-1 Plan, Beneficial Ownership